Global Phage Therapy Market Research Report 2022
SKU ID : QYR-21064823 | Publishing Date : 10-Jun-2022 | No. of pages : 110
Detailed TOC of Global Phage Therapy Market Research Report 2022
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Phage Therapy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 DsDNA Bacteriophage
1.2.3 SsDNA Bacteriophage
1.2.4 SsRNA Bacteriophage
1.2.5 Others
1.3 Market by Application
1.3.1 Global Phage Therapy Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Animal Health
1.3.3 Aquaculture
1.3.4 Agriculture
1.3.5 Food Industry
1.3.6 Human Health
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Phage Therapy Market Perspective (2017-2028)
2.2 Phage Therapy Growth Trends by Region
2.2.1 Phage Therapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Phage Therapy Historic Market Size by Region (2017-2022)
2.2.3 Phage Therapy Forecasted Market Size by Region (2023-2028)
2.3 Phage Therapy Market Dynamics
2.3.1 Phage Therapy Industry Trends
2.3.2 Phage Therapy Market Drivers
2.3.3 Phage Therapy Market Challenges
2.3.4 Phage Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Phage Therapy Players by Revenue
3.1.1 Global Top Phage Therapy Players by Revenue (2017-2022)
3.1.2 Global Phage Therapy Revenue Market Share by Players (2017-2022)
3.2 Global Phage Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Phage Therapy Revenue
3.4 Global Phage Therapy Market Concentration Ratio
3.4.1 Global Phage Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Phage Therapy Revenue in 2021
3.5 Phage Therapy Key Players Head office and Area Served
3.6 Key Players Phage Therapy Product Solution and Service
3.7 Date of Enter into Phage Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Phage Therapy Breakdown Data by Type
4.1 Global Phage Therapy Historic Market Size by Type (2017-2022)
4.2 Global Phage Therapy Forecasted Market Size by Type (2023-2028)
5 Phage Therapy Breakdown Data by Application
5.1 Global Phage Therapy Historic Market Size by Application (2017-2022)
5.2 Global Phage Therapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Phage Therapy Market Size (2017-2028)
6.2 North America Phage Therapy Market Size by Country (2017-2022)
6.3 North America Phage Therapy Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Phage Therapy Market Size (2017-2028)
7.2 Europe Phage Therapy Market Size by Country (2017-2022)
7.3 Europe Phage Therapy Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Phage Therapy Market Size (2017-2028)
8.2 Asia-Pacific Phage Therapy Market Size by Country (2017-2022)
8.3 Asia-Pacific Phage Therapy Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Phage Therapy Market Size (2017-2028)
9.2 Latin America Phage Therapy Market Size by Country (2017-2022)
9.3 Latin America Phage Therapy Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Phage Therapy Market Size (2017-2028)
10.2 Middle East & Africa Phage Therapy Market Size by Country (2017-2022)
10.3 Middle East & Africa Phage Therapy Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 NPO Microgen
11.1.1 NPO Microgen Company Detail
11.1.2 NPO Microgen Business Overview
11.1.3 NPO Microgen Phage Therapy Introduction
11.1.4 NPO Microgen Revenue in Phage Therapy Business (2017-2022)
11.1.5 NPO Microgen Recent Development
11.2 Proteon Pharmaceuticals
11.2.1 Proteon Pharmaceuticals Company Detail
11.2.2 Proteon Pharmaceuticals Business Overview
11.2.3 Proteon Pharmaceuticals Phage Therapy Introduction
11.2.4 Proteon Pharmaceuticals Revenue in Phage Therapy Business (2017-2022)
11.2.5 Proteon Pharmaceuticals Recent Development
11.3 Phagelux
11.3.1 Phagelux Company Detail
11.3.2 Phagelux Business Overview
11.3.3 Phagelux Phage Therapy Introduction
11.3.4 Phagelux Revenue in Phage Therapy Business (2017-2022)
11.3.5 Phagelux Recent Development
11.4 Intralytix
11.4.1 Intralytix Company Detail
11.4.2 Intralytix Business Overview
11.4.3 Intralytix Phage Therapy Introduction
11.4.4 Intralytix Revenue in Phage Therapy Business (2017-2022)
11.4.5 Intralytix Recent Development
11.5 Micreos
11.5.1 Micreos Company Detail
11.5.2 Micreos Business Overview
11.5.3 Micreos Phage Therapy Introduction
11.5.4 Micreos Revenue in Phage Therapy Business (2017-2022)
11.5.5 Micreos Recent Development
11.6 Eliava BioPreparations
11.6.1 Eliava BioPreparations Company Detail
11.6.2 Eliava BioPreparations Business Overview
11.6.3 Eliava BioPreparations Phage Therapy Introduction
11.6.4 Eliava BioPreparations Revenue in Phage Therapy Business (2017-2022)
11.6.5 Eliava BioPreparations Recent Development
11.7 Locus Biosciences,Inc
11.7.1 Locus Biosciences,Inc Company Detail
11.7.2 Locus Biosciences,Inc Business Overview
11.7.3 Locus Biosciences,Inc Phage Therapy Introduction
11.7.4 Locus Biosciences,Inc Revenue in Phage Therapy Business (2017-2022)
11.7.5 Locus Biosciences,Inc Recent Development
11.8 Pharmex Group,LLC
11.8.1 Pharmex Group,LLC Company Detail
11.8.2 Pharmex Group,LLC Business Overview
11.8.3 Pharmex Group,LLC Phage Therapy Introduction
11.8.4 Pharmex Group,LLC Revenue in Phage Therapy Business (2017-2022)
11.8.5 Pharmex Group,LLC Recent Development
11.9 Pherecydes Pharma
11.9.1 Pherecydes Pharma Company Detail
11.9.2 Pherecydes Pharma Business Overview
11.9.3 Pherecydes Pharma Phage Therapy Introduction
11.9.4 Pherecydes Pharma Revenue in Phage Therapy Business (2017-2022)
11.9.5 Pherecydes Pharma Recent Development
11.10 APS Biocontrol Ltd. (APS)
11.10.1 APS Biocontrol Ltd. (APS) Company Detail
11.10.2 APS Biocontrol Ltd. (APS) Business Overview
11.10.3 APS Biocontrol Ltd. (APS) Phage Therapy Introduction
11.10.4 APS Biocontrol Ltd. (APS) Revenue in Phage Therapy Business (2017-2022)
11.10.5 APS Biocontrol Ltd. (APS) Recent Development
11.11 Qingdao Phagepharm Bio-tech
11.11.1 Qingdao Phagepharm Bio-tech Company Detail
11.11.2 Qingdao Phagepharm Bio-tech Business Overview
11.11.3 Qingdao Phagepharm Bio-tech Phage Therapy Introduction
11.11.4 Qingdao Phagepharm Bio-tech Revenue in Phage Therapy Business (2017-2022)
11.11.5 Qingdao Phagepharm Bio-tech Recent Development
11.12 Fixed-Phage Limited
11.12.1 Fixed-Phage Limited Company Detail
11.12.2 Fixed-Phage Limited Business Overview
11.12.3 Fixed-Phage Limited Phage Therapy Introduction
11.12.4 Fixed-Phage Limited Revenue in Phage Therapy Business (2017-2022)
11.12.5 Fixed-Phage Limited Recent Development
11.13 Zeptometrix
11.13.1 Zeptometrix Company Detail
11.13.2 Zeptometrix Business Overview
11.13.3 Zeptometrix Phage Therapy Introduction
11.13.4 Zeptometrix Revenue in Phage Therapy Business (2017-2022)
11.13.5 Zeptometrix Recent Development
11.14 Phage International, Inc.
11.14.1 Phage International, Inc. Company Detail
11.14.2 Phage International, Inc. Business Overview
11.14.3 Phage International, Inc. Phage Therapy Introduction
11.14.4 Phage International, Inc. Revenue in Phage Therapy Business (2017-2022)
11.14.5 Phage International, Inc. Recent Development
11.15 MicroMir
11.15.1 MicroMir Company Detail
11.15.2 MicroMir Business Overview
11.15.3 MicroMir Phage Therapy Introduction
11.15.4 MicroMir Revenue in Phage Therapy Business (2017-2022)
11.15.5 MicroMir Recent Development
11.16 iNtODEWORLD, Inc.
11.16.1 iNtODEWORLD, Inc. Company Detail
11.16.2 iNtODEWORLD, Inc. Business Overview
11.16.3 iNtODEWORLD, Inc. Phage Therapy Introduction
11.16.4 iNtODEWORLD, Inc. Revenue in Phage Therapy Business (2017-2022)
11.16.5 iNtODEWORLD, Inc. Recent Development
11.17 NEXTBIOTICS
11.17.1 NEXTBIOTICS Company Detail
11.17.2 NEXTBIOTICS Business Overview
11.17.3 NEXTBIOTICS Phage Therapy Introduction
11.17.4 NEXTBIOTICS Revenue in Phage Therapy Business (2017-2022)
11.17.5 NEXTBIOTICS Recent Development
11.18 Armata Pharmaceuticals, Inc.
11.18.1 Armata Pharmaceuticals, Inc. Company Detail
11.18.2 Armata Pharmaceuticals, Inc. Business Overview
11.18.3 Armata Pharmaceuticals, Inc. Phage Therapy Introduction
11.18.4 Armata Pharmaceuticals, Inc. Revenue in Phage Therapy Business (2017-2022)
11.18.5 Armata Pharmaceuticals, Inc. Recent Development
11.19 Innophage
11.19.1 Innophage Company Detail
11.19.2 Innophage Business Overview
11.19.3 Innophage Phage Therapy Introduction
11.19.4 Innophage Revenue in Phage Therapy Business (2017-2022)
11.19.5 Innophage Recent Development
11.20 Adaptive Phage Therapeutics
11.20.1 Adaptive Phage Therapeutics Company Detail
11.20.2 Adaptive Phage Therapeutics Business Overview
11.20.3 Adaptive Phage Therapeutics Phage Therapy Introduction
11.20.4 Adaptive Phage Therapeutics Revenue in Phage Therapy Business (2017-2022)
11.20.5 Adaptive Phage Therapeutics Recent Development
11.21 TechnoPhage
11.21.1 TechnoPhage Company Detail
11.21.2 TechnoPhage Business Overview
11.21.3 TechnoPhage Phage Therapy Introduction
11.21.4 TechnoPhage Revenue in Phage Therapy Business (2017-2022)
11.21.5 TechnoPhage Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global Phage Therapy Market Research Report 2022
List of TablesTable 1. Global Phage Therapy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of DsDNA Bacteriophage
Table 3. Key Players of SsDNA Bacteriophage
Table 4. Key Players of SsRNA Bacteriophage
Table 5. Key Players of Others
Table 6. Global Phage Therapy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Phage Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Phage Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Phage Therapy Market Share by Region (2017-2022)
Table 10. Global Phage Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Phage Therapy Market Share by Region (2023-2028)
Table 12. Phage Therapy Market Trends
Table 13. Phage Therapy Market Drivers
Table 14. Phage Therapy Market Challenges
Table 15. Phage Therapy Market Restraints
Table 16. Global Phage Therapy Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Phage Therapy Market Share by Players (2017-2022)
Table 18. Global Top Phage Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phage Therapy as of 2021)
Table 19. Ranking of Global Top Phage Therapy Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Phage Therapy Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Phage Therapy Product Solution and Service
Table 23. Date of Enter into Phage Therapy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Phage Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Phage Therapy Revenue Market Share by Type (2017-2022)
Table 27. Global Phage Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Phage Therapy Revenue Market Share by Type (2023-2028)
Table 29. Global Phage Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Phage Therapy Revenue Market Share by Application (2017-2022)
Table 31. Global Phage Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Phage Therapy Revenue Market Share by Application (2023-2028)
Table 33. North America Phage Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 34. North America Phage Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 35. Europe Phage Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 36. Europe Phage Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 37. Asia-Pacific Phage Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 38. Asia-Pacific Phage Therapy Market Size by Region (2023-2028) & (US$ Million)
Table 39. Latin America Phage Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 40. Latin America Phage Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 41. Middle East & Africa Phage Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 42. Middle East & Africa Phage Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 43. NPO Microgen Company Detail
Table 44. NPO Microgen Business Overview
Table 45. NPO Microgen Phage Therapy Product
Table 46. NPO Microgen Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 47. NPO Microgen Recent Development
Table 48. Proteon Pharmaceuticals Company Detail
Table 49. Proteon Pharmaceuticals Business Overview
Table 50. Proteon Pharmaceuticals Phage Therapy Product
Table 51. Proteon Pharmaceuticals Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 52. Proteon Pharmaceuticals Recent Development
Table 53. Phagelux Company Detail
Table 54. Phagelux Business Overview
Table 55. Phagelux Phage Therapy Product
Table 56. Phagelux Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 57. Phagelux Recent Development
Table 58. Intralytix Company Detail
Table 59. Intralytix Business Overview
Table 60. Intralytix Phage Therapy Product
Table 61. Intralytix Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 62. Intralytix Recent Development
Table 63. Micreos Company Detail
Table 64. Micreos Business Overview
Table 65. Micreos Phage Therapy Product
Table 66. Micreos Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 67. Micreos Recent Development
Table 68. Eliava BioPreparations Company Detail
Table 69. Eliava BioPreparations Business Overview
Table 70. Eliava BioPreparations Phage Therapy Product
Table 71. Eliava BioPreparations Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 72. Eliava BioPreparations Recent Development
Table 73. Locus Biosciences,Inc Company Detail
Table 74. Locus Biosciences,Inc Business Overview
Table 75. Locus Biosciences,Inc Phage Therapy Product
Table 76. Locus Biosciences,Inc Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 77. Locus Biosciences,Inc Recent Development
Table 78. Pharmex Group,LLC Company Detail
Table 79. Pharmex Group,LLC Business Overview
Table 80. Pharmex Group,LLC Phage Therapy Product
Table 81. Pharmex Group,LLC Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 82. Pharmex Group,LLC Recent Development
Table 83. Pherecydes Pharma Company Detail
Table 84. Pherecydes Pharma Business Overview
Table 85. Pherecydes Pharma Phage Therapy Product
Table 86. Pherecydes Pharma Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 87. Pherecydes Pharma Recent Development
Table 88. APS Biocontrol Ltd. (APS) Company Detail
Table 89. APS Biocontrol Ltd. (APS) Business Overview
Table 90. APS Biocontrol Ltd. (APS) Phage Therapy Product
Table 91. APS Biocontrol Ltd. (APS) Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 92. APS Biocontrol Ltd. (APS) Recent Development
Table 93. Qingdao Phagepharm Bio-tech Company Detail
Table 94. Qingdao Phagepharm Bio-tech Business Overview
Table 95. Qingdao Phagepharm Bio-tech Phage TherapyProduct
Table 96. Qingdao Phagepharm Bio-tech Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 97. Qingdao Phagepharm Bio-tech Recent Development
Table 98. Fixed-Phage Limited Company Detail
Table 99. Fixed-Phage Limited Business Overview
Table 100. Fixed-Phage Limited Phage TherapyProduct
Table 101. Fixed-Phage Limited Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 102. Fixed-Phage Limited Recent Development
Table 103. Zeptometrix Company Detail
Table 104. Zeptometrix Business Overview
Table 105. Zeptometrix Phage TherapyProduct
Table 106. Zeptometrix Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 107. Zeptometrix Recent Development
Table 108. Phage International, Inc. Company Detail
Table 109. Phage International, Inc. Business Overview
Table 110. Phage International, Inc. Phage TherapyProduct
Table 111. Phage International, Inc. Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 112. Phage International, Inc. Recent Development
Table 113. MicroMir Company Detail
Table 114. MicroMir Business Overview
Table 115. MicroMir Phage TherapyProduct
Table 116. MicroMir Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 117. MicroMir Recent Development
Table 118. iNtODEWORLD, Inc. Company Detail
Table 119. iNtODEWORLD, Inc. Business Overview
Table 120. iNtODEWORLD, Inc. Phage TherapyProduct
Table 121. iNtODEWORLD, Inc. Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 122. iNtODEWORLD, Inc. Recent Development
Table 123. NEXTBIOTICS Company Detail
Table 124. NEXTBIOTICS Business Overview
Table 125. NEXTBIOTICS Phage TherapyProduct
Table 126. NEXTBIOTICS Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 127. NEXTBIOTICS Recent Development
Table 128. Armata Pharmaceuticals, Inc. Company Detail
Table 129. Armata Pharmaceuticals, Inc. Business Overview
Table 130. Armata Pharmaceuticals, Inc. Phage TherapyProduct
Table 131. Armata Pharmaceuticals, Inc. Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 132. Armata Pharmaceuticals, Inc. Recent Development
Table 133. Innophage Company Detail
Table 134. Innophage Business Overview
Table 135. Innophage Phage TherapyProduct
Table 136. Innophage Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 137. Innophage Recent Development
Table 138. Adaptive Phage Therapeutics Company Detail
Table 139. Adaptive Phage Therapeutics Business Overview
Table 140. Adaptive Phage Therapeutics Phage TherapyProduct
Table 141. Adaptive Phage Therapeutics Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 142. Adaptive Phage Therapeutics Recent Development
Table 143. TechnoPhage Company Detail
Table 144. TechnoPhage Business Overview
Table 145. TechnoPhage Phage TherapyProduct
Table 146. TechnoPhage Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 147. TechnoPhage Recent Development
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Phage Therapy Market Share by Type: 2021 VS 2028
Figure 2. DsDNA Bacteriophage Features
Figure 3. SsDNA Bacteriophage Features
Figure 4. SsRNA Bacteriophage Features
Figure 5. Others Features
Figure 6. Global Phage Therapy Market Share by Application in 2021 & 2028
Figure 7. Animal Health Case Studies
Figure 8. Aquaculture Case Studies
Figure 9. Agriculture Case Studies
Figure 10. Food Industry Case Studies
Figure 11. Human Health Case Studies
Figure 12. Others Case Studies
Figure 13. Phage Therapy Report Years Considered
Figure 14. Global Phage Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 15. Global Phage Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Phage Therapy Market Share by Region: 2021 VS 2028
Figure 17. Global Phage Therapy Market Share by Players in 2021
Figure 18. Global Top Phage Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phage Therapy as of 2021)
Figure 19. The Top 10 and 5 Players Market Share by Phage Therapy Revenue in 2021
Figure 20. North America Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. North America Phage Therapy Market Share by Country (2017-2028)
Figure 22. United States Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe Phage Therapy Market Share by Country (2017-2028)
Figure 26. Germany Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Phage Therapy Market Share by Region (2017-2028)
Figure 34. China Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Japan Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. South Korea Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Southeast Asia Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. India Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Australia Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Latin America Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Latin America Phage Therapy Market Share by Country (2017-2028)
Figure 42. Mexico Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Brazil Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Middle East & Africa Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Middle East & Africa Phage Therapy Market Share by Country (2017-2028)
Figure 46. Turkey Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Saudi Arabia Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. NPO Microgen Revenue Growth Rate in Phage Therapy Business (2017-2022)
Figure 49. Proteon Pharmaceuticals Revenue Growth Rate in Phage Therapy Business (2017-2022)
Figure 50. Phagelux Revenue Growth Rate in Phage Therapy Business (2017-2022)
Figure 51. Intralytix Revenue Growth Rate in Phage Therapy Business (2017-2022)
Figure 52. Micreos Revenue Growth Rate in Phage Therapy Business (2017-2022)
Figure 53. Eliava BioPreparations Revenue Growth Rate in Phage Therapy Business (2017-2022)
Figure 54. Locus Biosciences,Inc Revenue Growth Rate in Phage Therapy Business (2017-2022)
Figure 55. Pharmex Group,LLC Revenue Growth Rate in Phage Therapy Business (2017-2022)
Figure 56. Pherecydes Pharma Revenue Growth Rate in Phage Therapy Business (2017-2022)
Figure 57. APS Biocontrol Ltd. (APS) Revenue Growth Rate in Phage Therapy Business (2017-2022)
Figure 58. Qingdao Phagepharm Bio-tech Revenue Growth Rate in Phage Therapy Business (2017-2022)
Figure 59. Fixed-Phage Limited Revenue Growth Rate in Phage Therapy Business (2017-2022)
Figure 60. Zeptometrix Revenue Growth Rate in Phage Therapy Business (2017-2022)
Figure 61. Phage International, Inc. Revenue Growth Rate in Phage Therapy Business (2017-2022)
Figure 62. MicroMir Revenue Growth Rate in Phage Therapy Business (2017-2022)
Figure 63. iNtODEWORLD, Inc. Revenue Growth Rate in Phage Therapy Business (2017-2022)
Figure 64. NEXTBIOTICS Revenue Growth Rate in Phage Therapy Business (2017-2022)
Figure 65. Armata Pharmaceuticals, Inc. Revenue Growth Rate in Phage Therapy Business (2017-2022)
Figure 66. Innophage Revenue Growth Rate in Phage Therapy Business (2017-2022)
Figure 67. Adaptive Phage Therapeutics Revenue Growth Rate in Phage Therapy Business (2017-2022)
Figure 68. TechnoPhage Revenue Growth Rate in Phage Therapy Business (2017-2022)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Keyplayers in Global Phage Therapy Market Research Report 2022
NPO MicrogenProteon Pharmaceuticals
Phagelux
Intralytix
Micreos
Eliava BioPreparations
Locus Biosciences,Inc
Pharmex Group,LLC
Pherecydes Pharma
APS Biocontrol Ltd. (APS)
Qingdao Phagepharm Bio-tech
Fixed-Phage Limited
Zeptometrix
Phage International, Inc.
MicroMir
iNtODEWORLD, Inc.
NEXTBIOTICS
Armata Pharmaceuticals, Inc.
Innophage
Adaptive Phage Therapeutics
TechnoPhage